Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Versatility of uniplanar prearthoplastic distraction osteogenesis in the correction of post-ankylosis facial deformities-a report of five different cases.

Andrade NN, Aggarwal N, Mathai P, Nerurkar S.

Oral Maxillofac Surg. 2018 Dec;22(4):463-474. doi: 10.1007/s10006-018-0714-x. Epub 2018 Sep 10.

PMID:
30203137
2.

Intra-muscular haemangioma of the masseter: A clinical update and differential diagnosis of a rare entity.

Andrade N, Rajpari K, Mathai P, Aggarwal N, Nerurkar SA, Desai H.

J Stomatol Oral Maxillofac Surg. 2018 Dec;119(6):510-513. doi: 10.1016/j.jormas.2018.05.008. Epub 2018 Jun 5.

PMID:
29883629
3.

Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw.

Mathai PC, Andrade NN, Aggarwal N, Nerurkar S, Kapoor P.

Oral Maxillofac Surg. 2018 Jun;22(2):235-240. doi: 10.1007/s10006-018-0688-8. Epub 2018 Mar 5.

PMID:
29508096
4.

High-throughput chemical modification of oligonucleotides for systematic structure-activity relationship evaluation.

Zewge D, Gosselin F, Kenski DM, Li J, Jadhav V, Yuan Y, Nerurkar SS, Tellers DM, Flanagan WM, Davies IW.

Bioconjug Chem. 2014 Dec 17;25(12):2222-32. doi: 10.1021/bc500453q. Epub 2014 Nov 21.

PMID:
25398098
5.

Molecular umbrella conjugate for the ocular delivery of siRNA.

Janout V, Cline LL, Feuston BP, Klein L, O'Brien A, Tucker T, Yuan Y, O'Neill-Davis LA, Peiffer RL, Nerurkar SS, Jadhav V, Tellers DM, Regen SL.

Bioconjug Chem. 2014 Feb 19;25(2):197-201. doi: 10.1021/bc400506m. Epub 2014 Jan 23.

6.

Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.

Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, Turner GH, Ju H, Thomas H, Fishman CE, Sulpizio A, Behm DJ, Hoffman S, Lin Z, Lozinskaya I, Casillas LN, Lin M, Trout RE, Votta BJ, Thorneloe K, Lashinger ES, Figueroa DJ, Marquis R, Xu X.

J Pharmacol Exp Ther. 2008 Aug;326(2):443-52. doi: 10.1124/jpet.107.134551. Epub 2008 May 22. Erratum in: J Pharmacol Exp Ther. 2011 Jul;338(1):408-9.

PMID:
18499744
7.

In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.

Yue TL, Nerurkar SS, Bao W, Jucker BM, Sarov-Blat L, Steplewski K, Ohlstein EH, Willette RN.

J Pharmacol Exp Ther. 2008 May;325(2):466-74. doi: 10.1124/jpet.107.135327. Epub 2008 Feb 20.

PMID:
18287212
8.

Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.

Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL.

J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8.

PMID:
17577100
9.

P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.

Nerurkar SS, Olzinski AR, Frazier KS, Mirabile RC, O'Brien SP, Jing J, Rajagopalan D, Yue TL, Willette RN.

Biomarkers. 2007 Jan-Feb;12(1):87-112.

PMID:
17438656
10.

Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells.

Aiyar N, Disa J, Ao Z, Ju H, Nerurkar S, Willette RN, Macphee CH, Johns DG, Douglas SA.

Mol Cell Biochem. 2007 Jan;295(1-2):113-20. Epub 2006 Aug 8.

PMID:
16896535
11.

Lipopolysaccharide (LPS) contamination plays the real role in C-reactive protein-induced IL-6 secretion from human endothelial cells in vitro.

Nerurkar SS, McDevitt PJ, Scott GF, Johanson KO, Willette RN, Yue TL.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):e136. No abstract available.

PMID:
16127022
12.

Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities.

Polli JE, Yu LX, Cook JA, Amidon GL, Borchardt RT, Burnside BA, Burton PS, Chen ML, Conner DP, Faustino PJ, Hawi AA, Hussain AS, Joshi HN, Kwei G, Lee VH, Lesko LJ, Lipper RA, Loper AE, Nerurkar SG, Polli JW, Sanvordeker DR, Taneja R, Uppoor RS, Vattikonda CS, Wilding I, Zhang G.

J Pharm Sci. 2004 Jun;93(6):1375-81. No abstract available.

PMID:
15124197
13.

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.

Ju H, Behm DJ, Nerurkar S, Eybye ME, Haimbach RE, Olzinski AR, Douglas SA, Willette RN.

J Pharmacol Exp Ther. 2003 Dec;307(3):932-8. Epub 2003 Oct 15.

PMID:
14561851
14.

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.

Lenhard SC, Nerurkar SS, Schaeffer TR, Mirabile RC, Boyce RW, Adams DF, Jucker BM, Willette RN.

J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. Epub 2003 Oct 15.

PMID:
14561850
15.

Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.

Ju H, Nerurkar S, Sauermelch CF, Olzinski AR, Mirabile R, Zimmerman D, Lee JC, Adams J, Sisko J, Berova M, Willette RN.

J Pharmacol Exp Ther. 2002 Apr;301(1):15-20.

PMID:
11907152
16.

Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction.

Behr TM, Nerurkar SS, Nelson AH, Coatney RW, Woods TN, Sulpizio A, Chandra S, Brooks DP, Kumar S, Lee JC, Ohlstein EH, Angermann CE, Adams JL, Sisko J, Sackner-Bernstein JD, Willette RN.

Circulation. 2001 Sep 11;104(11):1292-8.

PMID:
11551882
17.

Corrected formula for estimating peripheral blood flow by impedance plethysmography.

Jindal GD, Nerurkar SN, Pednekar SA, Babu JP, Bhuta AC, Deshpande AK.

Med Biol Eng Comput. 1994 Nov;32(6):625-31.

PMID:
7723420
18.

Bioequivalence of racemic drugs.

Nerurkar SG, Dighe SV, Williams RL.

J Clin Pharmacol. 1992 Oct;32(10):935-43. Review.

PMID:
1447402
19.

Degradation and internalization of bound insulin in human erythrocytes.

Gambhir KK, Nerurkar SG.

Biochem Int. 1991 Jan;23(2):405-12.

PMID:
1859440
20.

Effect of pulmonary circulation on vector impedance cardiogram.

Pedhnekar SA, Jindal GD, Nerurkar SN, Dharani JB, Deshpande AK, Parulkar GB.

J Postgrad Med. 1990 Oct;36(4):213-8.

21.

Diagnosis of venous disorders using impedance plethysmography.

Jindal GD, Pedhnekar SA, Nerurkar SN, Masand KL, Gupta DK, Deshmukh HL, Bapu JP, Parulkar GB.

J Postgrad Med. 1990 Jul;36(3):158-63.

22.

Impedance plethysmographic observations in thoracic outlet syndrome.

Nerurkar SN, Jindal GD, Pedhenekar SA, Gupta DK, Deshpande AK, Deshmukh HL, Parulkar GB.

J Postgrad Med. 1990 Jul;36(3):154-7.

23.

Diagnosis of peripheral arterial occlusive diseases using impedance plethysmography.

Jindal GD, Nerurkar SN, Pedhnekar SA, Babu JP, Kelkar MD, Deshpande AK, Parulkar GB.

J Postgrad Med. 1990 Jul;36(3):147-53.

24.

Diagnosis of aortic occlusive diseases using impedance plethysmography.

Deshpande AK, Jindal GD, Babu IP, Nerurkar SN, Kelkar MD, Parulkar GB.

J Postgrad Med. 1990 Apr;36(2):80-2.

25.

A simpler procedure to study sodium-22 uptake (ouabain insensitive) in human erythrocytes.

Gambhir KK, Parui R, Nerurkar SG, Dave N, Mathews J, Mehrotra PP, Curry CL.

Clin Biochem. 1988 Jun;21(3):163-5.

PMID:
3390905
26.

Characterization of an intracellular insulin-degrading enzyme in human erythrocytes.

Gambhir KK, Nerurkar SG.

Biochem Med Metab Biol. 1988 Jun;39(3):284-9.

PMID:
3293635
27.

Usefulness of serum lipid and LCAT levels in diagnosing chronic hepatic dysfunction in liver cirrhosis.

Chadha MD, Abraham P, Nerurkar S, Taskar SP, Naik SR.

Indian J Gastroenterol. 1987 Oct;6(4):201-3. No abstract available.

PMID:
3679306
28.

Peroxidases induced in rat uterus by estrogen administration. II. Cytochemical and biochemical heterogeneity.

Anderson WA, Gabriel BW, Nerurkar SG, Wyche JH, Yates PE, Hanker JS.

J Submicrosc Cytol. 1986 Oct;18(4):683-90.

PMID:
3783793
29.

Study of hyperlipidemia in adults with nephrotic syndrome.

Khanna UB, Nerurkar SV, Almeida AF, Taskar SP, Acharya VN.

J Postgrad Med. 1985 Jul;31(3):140-5. No abstract available.

30.

Lipoprotein fractionation by precipitation (a comparison of two methods).

Nerurkar SV, Taskar SP.

J Postgrad Med. 1985 Apr;31(2):89-94. No abstract available.

31.

Rat erythrocyte insulin receptors: radioreceptor assay and characterization.

Ogunwole JO, Nerurkar SG, Hollis VW Jr.

J Natl Med Assoc. 1985 Feb;77(2):119-28.

32.

Metabolism of insulin in erythrocytes from renal failure patients on maintenance hemodialysis.

Nerurkar SG, Gambhir KK, Butterfield R, Cruz IA, Hosten AO, Dillard MG.

Uremia Invest. 1984-1985;8(2):103-9.

PMID:
6399647
33.

Insulin internalization in human erythrocytes.

Nerurkar SG, Gambhir KK.

Diabetologia. 1984 Jan;26(1):89. No abstract available.

PMID:
6368303
34.

Hyperlipidemia in patients with chronic renal failure.

Ravichandran R, Nerurkar SV, Acharya VN, Taskar SP.

J Postgrad Med. 1983 Oct;29(4):212-7. No abstract available.

35.

Lipid composition of plasma lipoproteins in treated diabetics.

Nerurkar SV, Retnam VJ, Taskar SP, Bhandarkar SD.

J Postgrad Med. 1983 Oct;29(4):201-11. No abstract available.

36.

Plasma lipids and lipoproteins in treated diabetics.

Retnam VJ, Nerurkar SV, Gupte MH, Bhandarkar SD, Taskar SP.

J Postgrad Med. 1983 Oct;29(4):193-200. No abstract available.

37.

Effect of storage on insulin receptor binding in human erythrocytes.

Gambhir KK, Nerurkar SG, Carter L, Brickler C, Giridhar G.

J Natl Med Assoc. 1983 May;75(5):503-7.

38.

Lipid profile in patients with myocardial infarction from the city of Bombay.

Taskar SP, Iyyer IR, Nerurkar SV, Sawant PN, Bhonsale DR, Kinare SG.

Indian Heart J. 1983 May-Jun;35(3):169-71. No abstract available.

PMID:
6629390
39.

Insulin receptor characteristics of erythrocytes from human newborns.

Gambhir KK, Nerurkar SG, Allen T, Hill RM, Sekhon HS, Westney LS.

J Natl Med Assoc. 1982 Apr;74(4):331-7.

40.

Apolipoprotein B in normolipemic and hyperlipoproteinaemic subjects from the city of Bombay.

Nerurkar SV, Iyyer IR, Taskar SP.

J Postgrad Med. 1982 Jan;28(1):13-7. No abstract available.

41.

Insulin binding and degradation by human erythrocytes at physiological temperature.

Gambhir KK, Nerurkar SG, Das PD, Archer JA, Henry WL Jr.

Endocrinology. 1981 Nov;109(5):1787-9.

PMID:
7028468
42.

Insulin degradation by human erythrocyte lysates.

Nerurkar SG, Gambhir KK.

Clin Chem. 1981 Apr;27(4):607-9.

43.
44.

Erythrocyte insulin receptors in chronic renal failure.

Gambhir KK, Archer JA, Nerurkar SG, Cruz IA, Sanders M.

Nephron. 1981;28(1):4-10. No abstract available.

PMID:
7266727
45.

Decreased erythrocyte insulin receptor binding in diabetic man with chronic renal failure.

Gambhir KK, Nerurkar SG, Cruz IA, Hosten AO.

Horm Metab Res. 1980 Aug;12(8):414-5. No abstract available.

PMID:
6997168
46.

Insulin receptor assay in human erythrocytes as an index to insulin sensitivity of body tissues.

Nerurkar SG, Gambhir KK.

Clin Chem. 1979 Sep;25(9):1672-3. No abstract available.

47.

Bisquaternary ammonium indolines and perhydroindoles in ganglionic blockade.

Mertes MP, Nerurkar SA, Walaszek EJ.

J Med Chem. 1968 Jan;11(1):106-11. No abstract available.

PMID:
5637152

Supplemental Content

Loading ...
Support Center